Skip to main navigation
Prelude Therapeutics
  • About
    • Overview
    • Leadership
    • Board of Directors
  • Science
    • Overview
    • Pipeline
    • CDK9
    • MCL1
    • CDK4/6
    • SMARCA2
    • Discovery Engine
    • Publications
  • Clinical Trials
    • Overview
    • PRT2527 Trials
    • PRT1419 Trials
    • PRT3645 Trials
    • PRT3789 Trials
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Financials
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quotes & Charts
      • Analysts
    • Governance
      • Governance Documents
      • Leadership
      • Committee Composition
    • Investor Resources
      • Investor FAQ's
      • Contact IR
      • Email Alerts
  • News
  • Life at Prelude
    • Overview
    • Open Positions
  • Contact

Stock Quotes & Charts

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
  • About
    • Overview
    • Leadership
    • Board of Directors
  • Science
    • Overview
    • Pipeline
    • CDK9
    • MCL1
    • CDK4/6
    • SMARCA2
    • Discovery Engine
    • Publications
  • Clinical Trials
    • Overview
    • PRT2527 Trials
    • PRT1419 Trials
    • PRT3645 Trials
    • PRT3789 Trials
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Financials
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quotes & Charts
      • Analysts
    • Governance
      • Governance Documents
      • Leadership
      • Committee Composition
    • Investor Resources
      • Investor FAQ's
      • Contact IR
      • Email Alerts
  • News
  • Life at Prelude
    • Overview
    • Open Positions
  • Contact

Stock Quote

Change
Volume
Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low

Stock Chart

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Print Page
RSS Feeds
Email Alerts
Search
preludetx.com

© Prelude Therapeutics
200 Powder Mill Road
Wilmington, DE 19803
(302) 467-1280

  • About
  • Science
  • Clinical Trials
  • Investors
  • News
  • Life at Prelude
  • Contact
visit our Twitter page visit our LinkedIn page Terms of Use Privacy Policy
logo
  • About
    • Overview
    • Leadership
    • Board of Directors
  • Science
    • Overview
    • Pipeline
    • CDK9
    • MCL1
    • CDK4/6
    • SMARCA2
    • Discovery Engine
    • Publications
  • Clinical Trials
    • Overview
    • PRT2527 Trials
    • PRT1419 Trials
    • PRT3645 Trials
    • PRT3789 Trials
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Financials
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quotes & Charts
      • Analysts
    • Governance
      • Governance Documents
      • Leadership
      • Committee Composition
    • Investor Resources
      • Investor FAQ's
      • Contact IR
      • Email Alerts
  • News
  • Life at Prelude
    • Overview
    • Open Positions
  • Contact